Nanoscope Therapeutics Hires Ray Kaczmarek as Chief Technology and Manufacturing Officer
Position
Chief Technical Officer
Company
Nanoscope Therapeutics
DallasBiotechnologyHealth CareMedicalTherapeuticsDescription
Nanoscope Therapeutics has appointed Ray Kaczmarek, an industry veteran and a recognized expert in gene therapy manufacturing, as the chief technology and manufacturing officer. Kaczmarek has extensive experience in leading operations, technology, and commercial supply strategies at pharmaceutical and biotechnology companies.
Quick answer
Nanoscope Therapeutics Hires Ray Kaczmarek as Chief Technology and Manufacturing Officer (December 6, 2024). Nanoscope Therapeutics is based in Dallas, Texas, United States.
- Who is the new Chief Technical Officer at Nanoscope Therapeutics?
- Nanoscope Therapeutics named Ray Kaczmarek Chief Technical Officer, announced December 6, 2024.
- What did Nanoscope Therapeutics announce on December 6, 2024?
- Nanoscope Therapeutics has appointed Ray Kaczmarek, an industry veteran and a recognized expert in gene therapy manufacturing, as the chief technology and manufacturing officer. Kaczmarek has extensive experience in leading operations, technology, and commercial supply strategies at pharmaceutical and biotechnology companies.
- What does Nanoscope Therapeutics do?
- Nanoscope Therapeutics is developing mutation-agnostic, sight-restoring optogenetic therapies for the millions of patients blinded by retinal degenerative diseases for which no treatment currently exists.
- Where is Nanoscope Therapeutics based?
- Nanoscope Therapeutics is based in Dallas, Texas, United States.
- Which similar companies made leadership changes around the same time?
- Incendia Therapeutics (December 3, 2024), On Target Laboratories (December 10, 2024), NYU Langone Health (December 20, 2024) and Faeth Therapeutics (November 22, 2024) also announced leadership changes within 45 days of Nanoscope Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Incendia Therapeutics Appoints Bradford Smith as Chief Financial Officer (December 3, 2024)
- On Target Laboratories Appoints Bill Peters as President and Chief Executive Officer (December 10, 2024)
- Perlmutter Cancer Center Appoints Dr. Anne S. Renteria as Site Director for Transplantation and Cellular Therapy Center (December 20, 2024)
- Faeth Therapeutics Appoints Dr. Stephen Hahn as Chief Medical Executive and Dr. Jayson Dallas as Chief Executive Officer (November 22, 2024)
- neurocare Group AG Appoints Kevin Reeder as Chief Financial Officer (November 21, 2024)
- Georgiamune Inc. Appoints Mark Avagliano as Chief Business Officer (November 19, 2024)
Who to call at Nanoscope Therapeutics, and when
A new leader at Nanoscope Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Nanoscope Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nanoscope Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nanoscope Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nanoscope Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Nanoscope Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.